“There is a lot of interest in the vaccine.
Despite the fact that in the first months there was a certain caution, there was, of course, a competitive - and not always conscientious - struggle, but nevertheless time has proved that the Russian scientific school, as well as the quality of this vaccine and its effectiveness, speak for themselves. ...
Today, there is already a great demand, which cannot be fully satisfied in these terms, but, nevertheless, colleagues from the Russian Direct Investment Fund and production sites, with the assistance of the Ministry of Industry and Trade, are working to increase production volumes, "he said.
The Ministry of Industry and Trade told about the great interest in "Sputnik V" abroad
At the same time, Gruzdev noted that the work related to the supply and production of "Sputnik V" abroad will continue, "including in the European direction."
In August 2020, Russia was the first in the world to register the Sputnik V coronavirus vaccine.
According to the results of the analysis, the effectiveness of the drug was 97.6% among Russians vaccinated with both components of the vaccine in the period from December 5, 2020 to March 31, 2021.
To date, the vaccine has been registered in more than 65 countries with a total population of over 3 billion people.